跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9 条关于
“REDEMPLO”
全部
9
临床试验
0
药物
1
机构
0
资讯
8
9个月前
Arrowhead Pharmaceuticals Soars 23% on FDA Approval of REDEMPLO for Rare Genetic Disease
10个月前
Arrowhead Pharmaceuticals Secures First FDA Approval with Redemplo for Rare Genetic Disorder
8个月前
Arrowhead Pharmaceuticals Reports Strong Q1 2026 Results with REDEMPLO Launch Success and Promising Obesity Pipeline Data
8个月前
Sanofi Secures Chinese Approval for Two Breakthrough Therapies Targeting Rare Cardiovascular and Metabolic Disorders
10个月前
FDA Approves First siRNA Therapy Plozasiran for Rare Metabolic Disorder Familial Chylomicronemia Syndrome
9个月前
Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia
9个月前
Arrowhead Pharmaceuticals Achieves FDA Approval for Rodemplo, Reports Strong Financial Turnaround
上个月
RNAi Therapeutics Expand Beyond the Liver as siRNA Drug Development Accelerates